Michelle L Apperson, MD; PhD

Associate Professor

  • 1106 Citations
  • 15 h-Index
1990 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Michelle L Apperson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Multiple Sclerosis Medicine & Life Sciences
Gene Expression Medicine & Life Sciences
Brain Medicine & Life Sciences
Exosomes Medicine & Life Sciences
Post-Synaptic Density Medicine & Life Sciences
etiracetam Medicine & Life Sciences
Duchenne Muscular Dystrophy Medicine & Life Sciences
Genes Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1990 2019

  • 1106 Citations
  • 15 h-Index
  • 25 Article
3 Citations (Scopus)

Exosomes Derived from Human Primed Mesenchymal Stem Cells Induce Mitosis and Potentiate Growth Factor Secretion

Yuan, O., Lin, C., Wagner, J., Archard, J. A., Deng, P., Halmai, J., Bauer, G., Fink, K., Fury, B., Perotti, N. H., Walker, J. E., Pollock, K., Apperson, M. L., Butters, J., Belafsky, P. C., Farwell, D. G., Kuhn, M., Nolta, J. & Anderson, J., Mar 15 2019, In : Stem Cells and Development. 28, 6, p. 398-409 12 p.

Research output: Contribution to journalArticle

Exosomes
Mesenchymal Stromal Cells
Mitosis
Intercellular Signaling Peptides and Proteins
Proteins
1 Citation (Scopus)

Primed mesenchymal stem cells package exosomes with metabolites associated with immunomodulation

Showalter, M. R., Wancewicz, B., Fiehn, O., Archard, J. A., Clayton, S., Wagner, J., Deng, P., Halmai, J., Fink, K., Bauer, G., Fury, B., Perotti, N. H., Apperson, M. L., Butters, J., Belafsky, P. C., Farwell, D. G., Kuhn, M., Nolta, J. & Anderson, J., Jan 1 2019, In : Biochemical and Biophysical Research Communications.

Research output: Contribution to journalArticle

Open Access
Exosomes
Immunomodulation
Metabolites
Stem cells
Mesenchymal Stromal Cells
29 Citations (Scopus)

Phase 2 trial of ibudilast in progressive multiple sclerosis

Fox, R. J., Coffey, C. S., Conwit, R., Cudkowicz, M. E., Gleason, T., Goodman, A., Klawiter, E. C., Matsuda, K., McGovern, M., Naismith, R. T., Ashokkumar, A., Barnes, J., Ecklund, D., Klingner, E., Koepp, M., Long, J. D., Natarajan, S., Thornell, B., Yankey, J., Bermel, R. A. & 35 others, Debbins, J. P., Huang, X., Jagodnik, P., Lowe, M. J., Nakamura, K., Narayanan, S., Sakaie, K. E., Thoomukuntla, B., Zhou, X., Krieger, S., Alvarez, E., Apperson, M. L., Bashir, K., Cohen, B. A., Coyle, P. K., Delgado, S., Dewitt, L. D., Flores, A., Giesser, B. S., Goldman, M. D., Jubelt, B., Lava, N., Lynch, S. G., Moses, H., Ontaneda, D., Perumal, J. S., Racke, M., Repovic, P., Riley, C. S., Severson, C., Shinnar, S., Suski, V., Weinstock-Guttman, B., Yadav, V. & Zabeti, A., Aug 30 2018, In : New England Journal of Medicine. 379, 9, p. 846-855 10 p.

Research output: Contribution to journalArticle

Multiple Sclerosis
Brain
Placebos
Chronic Progressive Multiple Sclerosis
Atrophy
84 Citations (Scopus)

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

EXPAND Clinical Investigators, Mar 31 2018, In : The Lancet. 391, 10127, p. 1263-1273 11 p.

Research output: Contribution to journalArticle

Chronic Progressive Multiple Sclerosis
Placebos
1-(4-(1-((E)-4-cyclohexyl-3-trifluoromethylbenzyloxyimino)-ethyl)-2-ethylbenzyl)-azetidine-3-carboxylic acid
Bradycardia
Safety

Engaging U.S. veterans with PTSD in online therapy

Parish, M. B., Apperson, M. & Yellowlees, P. M., May 1 2014, In : Psychiatric Services. 65, 5, p. 697 1 p.

Research output: Contribution to journalArticle

Veterans
Post-Traumatic Stress Disorders
Psychotherapy
Internet
Young Adult